Literature DB >> 10160109

Industry comment on the 1995 revised Australian pharmacoeconomic guidelines.

M P Grobler1, K Macarounas-Kirchmann, G A Pearce, M Stafford.   

Abstract

Mesh：

Year:  1996        PMID： 10160109     DOI： 10.2165/00019053-199609040-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  2 in total

1.  The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals.

Authors:  J L Glennie; G W Torrance; J F Baladi; C Berka; E Hubbard; D Menon; N Otten; M Rivière
Journal:  Pharmacoeconomics       Date:  1999-05       Impact factor: 4.981

2.  Using economic evaluations to make formulary coverage decisions. So much for guidelines.

Authors:  A H Anis; Y Gagnon
Journal:  Pharmacoeconomics       Date:  2000-07       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.